| pubmed-article:10861427 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:10861427 | lifeskim:mentions | umls-concept:C1516213 | lld:lifeskim |
| pubmed-article:10861427 | lifeskim:mentions | umls-concept:C1332128 | lld:lifeskim |
| pubmed-article:10861427 | lifeskim:mentions | umls-concept:C0017189 | lld:lifeskim |
| pubmed-article:10861427 | lifeskim:mentions | umls-concept:C0002475 | lld:lifeskim |
| pubmed-article:10861427 | lifeskim:mentions | umls-concept:C0442120 | lld:lifeskim |
| pubmed-article:10861427 | pubmed:issue | 11 | lld:pubmed |
| pubmed-article:10861427 | pubmed:dateCreated | 2000-9-11 | lld:pubmed |
| pubmed-article:10861427 | pubmed:abstractText | Most patients with peritoneal carcinomatosis of digestive tract origin die within 6 months. Intraperitoneal chemohyperthermia (IPCH) associated with surgery has been reported as a possible new therapeutic approach. | lld:pubmed |
| pubmed-article:10861427 | pubmed:language | eng | lld:pubmed |
| pubmed-article:10861427 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10861427 | pubmed:citationSubset | AIM | lld:pubmed |
| pubmed-article:10861427 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10861427 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10861427 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:10861427 | pubmed:month | Jun | lld:pubmed |
| pubmed-article:10861427 | pubmed:issn | 0008-543X | lld:pubmed |
| pubmed-article:10861427 | pubmed:author | pubmed-author:BienvenuJJ | lld:pubmed |
| pubmed-article:10861427 | pubmed:author | pubmed-author:VignauAA | lld:pubmed |
| pubmed-article:10861427 | pubmed:author | pubmed-author:GillyF NFN | lld:pubmed |
| pubmed-article:10861427 | pubmed:author | pubmed-author:PanteixGG | lld:pubmed |
| pubmed-article:10861427 | pubmed:author | pubmed-author:CaillotJ LJL | lld:pubmed |
| pubmed-article:10861427 | pubmed:author | pubmed-author:FrancoisYY | lld:pubmed |
| pubmed-article:10861427 | pubmed:author | pubmed-author:GarbitFF | lld:pubmed |
| pubmed-article:10861427 | pubmed:author | pubmed-author:GrandclémentE... | lld:pubmed |
| pubmed-article:10861427 | pubmed:author | pubmed-author:GlehenOO | lld:pubmed |
| pubmed-article:10861427 | pubmed:author | pubmed-author:BeaujardA CAC | lld:pubmed |
| pubmed-article:10861427 | pubmed:copyrightInfo | Copyright 2000 American Cancer Society. | lld:pubmed |
| pubmed-article:10861427 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:10861427 | pubmed:day | 1 | lld:pubmed |
| pubmed-article:10861427 | pubmed:volume | 88 | lld:pubmed |
| pubmed-article:10861427 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:10861427 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:10861427 | pubmed:pagination | 2512-9 | lld:pubmed |
| pubmed-article:10861427 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
| pubmed-article:10861427 | pubmed:meshHeading | pubmed-meshheading:10861427... | lld:pubmed |
| pubmed-article:10861427 | pubmed:meshHeading | pubmed-meshheading:10861427... | lld:pubmed |
| pubmed-article:10861427 | pubmed:meshHeading | pubmed-meshheading:10861427... | lld:pubmed |
| pubmed-article:10861427 | pubmed:meshHeading | pubmed-meshheading:10861427... | lld:pubmed |
| pubmed-article:10861427 | pubmed:meshHeading | pubmed-meshheading:10861427... | lld:pubmed |
| pubmed-article:10861427 | pubmed:meshHeading | pubmed-meshheading:10861427... | lld:pubmed |
| pubmed-article:10861427 | pubmed:meshHeading | pubmed-meshheading:10861427... | lld:pubmed |
| pubmed-article:10861427 | pubmed:meshHeading | pubmed-meshheading:10861427... | lld:pubmed |
| pubmed-article:10861427 | pubmed:meshHeading | pubmed-meshheading:10861427... | lld:pubmed |
| pubmed-article:10861427 | pubmed:meshHeading | pubmed-meshheading:10861427... | lld:pubmed |
| pubmed-article:10861427 | pubmed:meshHeading | pubmed-meshheading:10861427... | lld:pubmed |
| pubmed-article:10861427 | pubmed:meshHeading | pubmed-meshheading:10861427... | lld:pubmed |
| pubmed-article:10861427 | pubmed:meshHeading | pubmed-meshheading:10861427... | lld:pubmed |
| pubmed-article:10861427 | pubmed:meshHeading | pubmed-meshheading:10861427... | lld:pubmed |
| pubmed-article:10861427 | pubmed:meshHeading | pubmed-meshheading:10861427... | lld:pubmed |
| pubmed-article:10861427 | pubmed:meshHeading | pubmed-meshheading:10861427... | lld:pubmed |
| pubmed-article:10861427 | pubmed:meshHeading | pubmed-meshheading:10861427... | lld:pubmed |
| pubmed-article:10861427 | pubmed:year | 2000 | lld:pubmed |
| pubmed-article:10861427 | pubmed:articleTitle | Intraperitoneal chemohyperthermia with mitomycin C for digestive tract cancer patients with peritoneal carcinomatosis. | lld:pubmed |
| pubmed-article:10861427 | pubmed:affiliation | Oncologic Hyperthermia Laboratory, Université C.B. Lyon-I, Oullins, France. | lld:pubmed |
| pubmed-article:10861427 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:10861427 | pubmed:publicationType | Clinical Trial | lld:pubmed |
| pubmed-article:10861427 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| pubmed-article:10861427 | pubmed:publicationType | Clinical Trial, Phase II | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:10861427 | lld:pubmed |
